NCT04920292View on ClinicalTrials.gov

PK, Safety and Tolerability of Single and Multiple Doses of Oxfendazole Tablets

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

April 21, 2022

Primary Completion Date

November 7, 2022

Study Completion Date

November 14, 2022

Conditions
Filariasis
Interventions
DRUG

Oxfendazole

Oxfendazole is a benzimidazole anthelminthic drug.

DRUG

Placebo

The placebo tablet is made using the same non-active ingredients and matches the investigational tablet.

Trial Locations (1)

Unknown

Ifakara Health Institute, Bagamoyo

All Listed Sponsors
collaborator

Ifakara Health Institute

OTHER

collaborator

Drugs for Neglected Diseases

OTHER

lead

Swiss Tropical & Public Health Institute

OTHER